- Home
- IMUX vs AIRS Comparison
IMUX vs AIRS Comparison
Compare IMUX & AIRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMUX | AIRS |
|---|---|---|
| Founded | 2016 | 2012 |
| Country | United States | United States |
| Employees | 66 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 152.6M | 169.8M |
| IPO Year | 2013 | 2021 |
Fundamental Metrics
Financial Performance| Metric | IMUX | AIRS |
|---|---|---|
| Price | $1.18 | $2.62 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $4.80 | N/A |
| AVG Volume (30 Days) | 1.8M | ★ 5.1M |
| Earning Date | 05-14-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $151,818,000.00 |
| Revenue This Year | N/A | $5.30 |
| Revenue Next Year | N/A | $6.49 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.51 | $1.51 |
| 52 Week High | $1.51 | $12.00 |
Technical Indicators
Market Signals| Indicator | IMUX | AIRS |
|---|---|---|
| Relative Strength Index (RSI) | 53.23 | 49.52 |
| Support Level | $1.05 | $2.52 |
| Resistance Level | $1.35 | $3.36 |
| Average True Range (ATR) | 0.11 | 0.38 |
| MACD | -0.01 | -0.06 |
| Stochastic Oscillator | 53.13 | 25.22 |
Price Performance
Historical ComparisonAbout IMUX Immunic Inc.
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function. It operates in one segment which is Life science segment.
About AIRS AirSculpt Technologies Inc.
AirSculpt Technologies Inc is a national provider of body contouring procedures delivering a premium consumer experience under its brand Elite Body Sculpture. Elite Body Sculpture, provides custom body contouring using the proprietary AirSculpt method that removes unwanted fat in a minimally invasive procedure. The company has one operating and reportable segment, direct medical procedure services.